Suffer From Peanut Allergies? A New Treatment Could Reduce Your Everyday Fears [Fortune]
AIMMUNE THERAPEUTICS (AIMT)
Last aimmune therapeutics earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aimmune.com/corporate-profile
Company Research
Source: Fortune
By Natasha Bach 8:26 AM EST U.S. drug developer Aimmune Therapeutics has made significant strides toward developing a preventive treatment for peanut allergies. The company has created peanut powder capsules intended to help children build a tolerance to the legume, via gradual exposure, reports the Associated Press . Read: Parents Are Saying Peter Rabbit Is an ‘Allergy Bully Aimmune studied close to 500 children ages 4 to 17 with severe peanut allergies, giving the children either the peanut capsules or a dummy powder in increasing quantities over a period of six months. Then, for an additional six months, they continued to take the capsule at the final amount. By the end of the study, 67% of those with the experimental treatment were able to consume the equivalent of about two peanuts, as compared to 4% of those give
Show less
Read more
Impact Snapshot
Event Time:
AIMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AIMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AIMT alerts
High impacting AIMMUNE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics